Login
$ABT
$103.52 -$1.36 (1.3%) Live

Ownership

13F as of Q2 2026 · 1.73B shares outstanding

Who owns ABT?

By type of holder
Institutions 79.5% Insiders 0.0% Everyone else 20.5%
Concentration Top 10 holders own 35.2%
BlackRock, Inc. 8.8% · Vanguard Capital Management LLC 6.6%
Institutional ownership
79.5%
-0.0 pts vs last qtr
Institutional holders
2,976
-146 vs last qtr
Net shares bought
−599.3K
by institutions in Q2 2026
New / sold out
192 / 338
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Norges Bank NEW +23.4M
  • Charles Schwab Investment Management Inc +14.2M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Wellington Management Group LLP −18.8M
  • Capital Research Global Investors −12.9M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$50.9M
12 notices from 8 people
Shares covered
447.3K
0.03% of the company
Arranged in advance
0%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$23.4M$46.8MNov 2025: $203.0K without a planNovDecJanFebMar 2026: $485.3K without a planMarApr 2026: $2.7M without a planAprMay 2026: $646.8K without a planMayJunJulAug 2026: $46.8M without a planAugSep 2026: $3.0K without a planSepOct
Largest proposed sellers
  • Robert B. Ford Officer $46.2M
  • Robert J. Alpern Retired director $3.35M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+17.9%
+1.84% a year
Each share's claim on the business
−15.2%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$11.5B vs $5.56B
over 10 fiscal years
Diluted shares, split-adjusted
1.44B1.62B1.81B2016: 1.48B shares'162017: 1.75B shares'172018: 1.77B shares'182019: 1.78B shares'192020: 1.79B shares'202021: 1.79B shares'212022: 1.76B shares'222023: 1.75B shares'232024: 1.75B shares'242025: 1.75B shares'25
Buybacks Stock-based comp
$0$1.9B$3.8B2016 buybacks: $522.0M2016 stock comp: $310.0M'162017 buybacks: $117.0M2017 stock comp: $406.0M'172018 buybacks: $238.0M2018 stock comp: $477.0M'182019 buybacks: $718.0M2019 stock comp: $519.0M'192020 buybacks: $403.0M2020 stock comp: $546.0M'202021 buybacks: $2.3B2021 stock comp: $640.0M'212022 buybacks: $3.8B2022 stock comp: $685.0M'222023 buybacks: $1.23B2023 stock comp: $644.0M'232024 buybacks: $1.3B2024 stock comp: $673.0M'242025 buybacks: $893.0M2025 stock comp: $664.0M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years87% 3–5 years2% 1–3 years3% Under 1 year8%
Quarterly turnover
10.7%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting ABT on Form 13F
B
BlackRock, Inc.
Shares
152.6M
% of company
8.82%
Change vs last qtr
+6.9M (+4.7%)
Held since
≤2021
VC
Vanguard Capital Management LLC
Shares
113.8M
% of company
6.57%
Change vs last qtr
+801.1K (+0.7%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Abbott Laboratories, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting ABT on Form N-PORT; together they hold 32.5% of the company
VT
Position value
$5.02B
% of company
3.20%
% of the fund
0.22%
As of
June 30, 2026
V5
Vanguard Index Funds
Position value
$4.1B
% of company
2.61%
% of the fund
0.25%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Abbott Laboratories and how much of the fund the position is.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support